Updated: Jun 21, 2026

A Screenable In Vivo Assay for Mitochondrial Modulators Using Transgenic Bioluminescent Caenorhabditis elegans
Published on: October 16, 2015
Shamol Saha1, Maria D Guillily, Andrew Ferree
1Department of Pharmacology, Boston University School of Medicine, Boston, Massachusetts 02118, USA.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Leucine-rich repeat kinase 2 (LRRK2) protects against mitochondrial toxins in C. elegans. Mutations linked to Parkinson's disease may increase dopaminergic neuron vulnerability to such stressors.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: